新的研究表明,减肥药物可能比仅仅饮食减少与肥胖有关的癌症的风险。 New study suggests weight loss drugs may cut risk of obesity-related cancers more than diet alone.

新的研究表明,减重药物,如利拉甘酸盐和排他性药物,可能会使与肥胖有关的癌症的风险比仅体重损失就减少高达41%。 New research suggests that weight loss medications, such as liraglutide and exenatide, may reduce the risk of obesity-related cancers by up to 41% more than weight loss alone. 根据6 356名病人提供的数据,这项研究表明,这些药物除了促进减肥外,还可能带来抗癌的好处。 The study, based on data from 6,356 patients, indicates these drugs may have anti-cancer benefits beyond promoting weight loss. 研究人员发现,在使用这些药物的病人和接受小儿科外科手术的病人中,癌症发病率相似,尽管还需要进一步研究才能证实这些结果。 Researchers found similar cancer rates among patients using these medications and those who had bariatric surgery, though further studies are needed to confirm these findings.